Day 61 or later If more blood sugar control is needed, your health care professional may increase your dose to 9 mg once daily
Are injections better than oral supplements
SYNERGY-NASH: Tirzepatide and metabolic steatohepatitis (MASH) SYNERGY-NASH (Loomba et al., NEJM 2024, NEJMoa2401943, PMID 38856224) is a phase 2 trial in 190 patients with metabolic steatohepatitis (MASH) and biopsy-proven stage 2 or 3 fibrosis
Rated 5 out of 5 Stephanie M
Our team will examine your vitals, weight, measurements, and blood samples for testing
For women experiencing hormonal changes during significant life phases, such as menopause, managing body mass can become particularly challenging